What is Oral Parity, and Why Does it Matter?
We answer this question with the help of a pharmacist at a large oncology practice who wishes to remain…
01/08/2021
What is Oral Parity, and Why Does it Matter?
We answer this question with the help of a pharmacist at a large oncology practice who wishes to remain…
|
01/08/2021
AIM Launches a New Program That Addresses the Emotional Needs of Melanoma Patients
by Mara Klecker Amid the COVID-19 pandemic, AIM at Melanoma has redoubled its efforts to meet the needs of melanoma…
11/24/2020
Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma
Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
|
|
11/24/2020
Donor Spotlight: Gina Roller
Friendship is Forever By Mara Klecker Gina Roller’s best friend, Kerri-Lynn Larimer, adopted and lived by the motto “crazy not…
|
|
11/12/2020
Melanoma by the State: North Dakota
North Dakota Wants Residents to Protect Their Skin North Dakota is a farming and ranching state, with 39.1 million acres…
|
11/12/2020
President’s Letter | November 2020
From the Desk of Samantha Guild It’s hard to believe that we’re nearing the holiday season and the end of…
|
11/12/2020
Survivor Spotlight: Stephanie Bowen, Stage IV Survivor
A Woman of Determination By Mara Klecker The second diagnosis came just days before Christmas 2010, almost exactly a decade…
|
11/12/2020
Survivor Spotlight: Tom Lauritzen, Stage III Survivor
On the Road Again…Soon By, Alicia Rowell Tom Lauritzen has lived his whole life in Pittsburgh, Pennsylvania, save for a…
|
11/12/2020
In Plain English—Neo-Adjuvant Therapy for Palpable/Resectable Stage III Melanoma
By Kim Margolin, M.D. In this chapter of “In Plain English,” we will describe the concept of neo-adjuvant therapy. Certain terms…
|
09/29/2020
Have You Checked Out Our New Website?
AIM announced the launch of our redesigned website last week. Have you had an opportunity to take a look? Every…
Recent Posts
Jan. 21, 2025
Replimune Announces BLA Acceptance and Priority Review for RP1 for the Treatment in Advanced Melanoma
Jan. 14, 2025
Meaning-Centered Psychotherapy: Finding Purpose in the Face of Cancer
Jan. 09, 2025
What Inspires Leading Melanoma Researchers?
Dec. 30, 2024
Jimmy Carter: A Life that Shaped Cancer Treatment and Hope for Melanoma Patients
Dec. 27, 2024